MOR

Morphosys AG
69.36 EUR
+0.92 +1.344%
1m
5m
15m
30m
1H
4H
1D
1W
  • Full Name Morphosys AG
  • Currency EUR
  • Spread Type Floating
  • Margin 20%
  • Min traded quantity 25
  • Trading hours Mon - Fri 07:00 - 15:30 (UTC)
  • Long position overnight fee -0.0100%
  • Short position overnight fee -0.0122%
  • Overnight fee time 21:00 PM
  • Derivative Type Contract for Difference

Morphosys AG

Based in Martinsried, Germany, MorphoSys (MOR) is a pharmaceutical company committed to antibody development. All antibodies, created by MorphoSys, are composed of 100% protein. The company’s most advanced technology, HuCAL, is designed to approach drug discovery in a smart new way. In total, MorphoSys has developed a portfolio of over 100 human antibodies built with such compounds as guselkumab, anetumab ravtansine, gantenerumab. MorphoSys stock is quoted at Frankfurt Stock Exchange. The company is featured in the TecDAX index. Stay tuned to the MOR stock price info with Capital.com.
Ready to get started?
Send me the link to download Capital.com app. Download Capital.com